2 of 6
ZHANG ET AL.
was washed with toluene (2 × 15 ml) and dried in vacuo.
The synthesis route is shown in Scheme 1.
2 | EXPERIMENTAL
2.1 | General
1a Yield: 88.0%. 1H NMR (400 MHz, DMSO‐d6, δ,
ppm): 8.24 (s, 1H, imidazol), 7.66 (s, 1H, imidazol),
7.51–7.76 (m, 10H, Ph), 4.31 (m, 2NCH2), 3.81 (s, 3H,
NCH3), 3.72 (t, J = 8 Hz, 2H, OCH2CH2N), 3.21 (s, 3H,
OCH3). 13C NMR (100 MHz, DMSO‐d6, δ, ppm): 141.5
(imidazol), 139.7 (Ph), 132.5 (Ph), 128.9 (Ph), 125.1 (Ph),
123.4 (imidazol), 123.2 (imidazol), 68.7 (NCH2CH2O),
59.1 (OCH3), 49.3 (NCH2CH2O), 36.5 (NCH3). 31P NMR
(DMSO‐d6, δ, ppm): −31.5.
Styrene was washed with 5% NaOH and dried with
Na2SO4. After filtration, the styrene was distilled under
reduced pressure. All other substances were purchased
from Aldrich and were used as received.
Gas chromatography: Trace DSQ GC column = DB‐5
30 m × 2.5 mm × 0.25 μm, split = 50:1, flow = 1 ml min−1
constant flow, inlet temperature = 260 °C, column temper-
ature = 50 °C (hold 1 min) then 15 °C min−1 up to 260 °C
(hold 10 min).
2a Yield: 85.7%. 1H NMR (400 MHz, DMSO‐d6, δ,
ppm): 7.97 (s, 1H, imidazol), 7.67 (s, 1H, imidazol),
7.50–7.77 (m, 10H, Ph), 4.33 (m, 2NCH2), 3.87 (s, 3H,
NCH3), 3.71 (t, J = 8 Hz, 2H, OCH2CH2N), 3.51 (s, 4H,
(OCH2CH2)), 3.21 (s, 3H, OCH3). 13C NMR (100 MHz,
DMSO‐d6, δ, ppm): 141.1 (imidazol), 139.7 (Ph), 132.5
(Ph), 128.1 (Ph), 125.1 (Ph), 123.8 (imidazol), 123.2
(imidazol), 69.4 (CH2CH2O), 68.1 (NCH2CH2O), 59.1
(OCH3), 49.5 (NCH2CH2O), 35.9 (NCH3). 31P NMR
(DMSO‐d6, δ, ppm): −31.8.
1H NMR, 13C NMR and 31P NMR spectra were mea-
sured using a Bruker AV400 spectrometer operating at
400.13, 100.62 and 161.97 MHz, respectively. Chemical
1
shifts for H NMR and 13C NMR spectra were recorded
in ppm relative to residual proton of deuterated
dimethylsulfoxide (DMSO‐d6) (1H, 2.50 ppm; 13C
39.5 ppm). 31P NMR chemical shifts are relative to 85%
H3PO4 external standard.
3a Yield: 86.1%. 1H NMR (400 MHz, DMSO‐d6, δ,
ppm): 7.91 (s, 1H, imidazol), 7.64 (s, 1H, imidazol),
7.51–7.76 (m, 10H, Ph), 4.30 (m, 2NCH2), 3.80 (s, 3H,
NCH3), 3.75 (t, J = 8 Hz, 2H, OCH2CH2N), 3.53 (s,
(OCH2CH2)6), 3.21 (s, 3H, OCH3). 13C NMR (100 MHz,
DMSO‐d6, δ, ppm): 141.6 (imidazol), 139.3 (Ph), 132.8
(Ph), 128.0 (Ph), 125.1 (Ph), 123.5 (imidazol), 123.4
(imidazol), 69.5 ((CH2CH2O)6), 68.1 (NCH2CH2O), 59.1
(OCH3), 49.3 (NCH2CH2O), 36.7 (NCH3). 31P NMR
(DMSO‐d6, δ, ppm): −33.1.
2.2 | Preparation of mPEG‐im‐PPh2
Monomethoxy PEG (0.1 mol) was dissolved in toluene
(100 ml) in a 250 ml three‐necked flask and the stirred
solution was heated at reflux for 2 h to remove the water
contained in the PEG by azeotropic dehydration. After
cooling, dried pyridine (0.125 mol) was added to the solu-
tion and then thionyl chloride (0.125 mol) was added
dropwise with stirring. The color of the solution changed
from faint yellow to reddish brown. The reaction mixture
was stirred for 24 h at 80 °C. After cooling to room tem-
perature, a mixture of hydrochloric acid (8 ml) and water
(16 ml) was added and stirred, and the layers were
allowed to separate, and the lower layer was twice
extracted with toluene. The extracts were combined with
the upper organic phase and the solvent was removed
under vacuum to afford monomethoxy PEG chloride. A
mixture of monomethoxy PEG chloride (10.0 mmol) and
1‐alkylimidazole (11.0 mmol) was diluted in 1,1,1‐
trichloroethane (10.0 ml), and the solution was refluxed
for 36 h and the phases were separated. The lower phase
was washed twice with 5 ml of 1,1,1‐trichloroethane and
once with 10.0 ml of ethyl ether. Residual solvents were
removed by rotary evaporation. Removal of the solvent
under vacuum afforded a yellow oil (mPEGBImCl). A
solution of LiPPh2, freshly prepared from Li (0.8 g,
0.11 mol) and PPh3 (13.1 g, 0.05 mol), in tetrahydrofuran
(THF; 50 ml), was added to a solution of mPEGBImCl
(0.05 mol) in THF (50 ml). The mixture was stirred for
1 h at room temperature, then the supernatant was
decanted off and the remaining solid mPEG‐im‐PPh2
4a Yield: 84.7%. 1H NMR (400 MHz, DMSO‐d6, δ,
ppm): 7.89 (s, 1H, imidazol), 7.67 (s, 1H, imidazol),
7.49–7.77 (m, 10H, Ph), 4.31 (m, 2H, 2NCH2), 3.83 (s,
3H, NCH3), 3.77 (t, J = 8 Hz, 2H, OCH2CH2N), 3.50 (s,
(OCH2CH2)10), 3.23 (s, 3H, OCH3). 13C NMR (100 MHz,
DMSO‐d6, δ, ppm): 140.6 (imidazol), 139.1 (Ph), 132.3
(Ph), 128.4 (Ph), 125.7 (Ph), 123.1 (imidazol), 123.5
(imidazol), 69.1 ((CH2CH2O)10), 67.9 (NCH2CH2O), 58.1
(OCH3), 45.3 (NCH2CH2O), 35.7 (NCH3). 31P NMR
(DMSO‐d6, δ, ppm): −33.9.
5a Yield: 83.6%. 1H NMR (400 MHz, DMSO‐d6, δ,
ppm): 7.93 (s, 1H, imidazol), 7.67 (s, 1H, imidazol),
7.51–7.73 (m, 10H, Ph), 4.31 (m, 2NCH2), 3.85 (s, 3H,
NCH3), 3.73 (t, J = 8 Hz, 2H, OCH2CH2N), 3.51 (s,
(OCH2CH2)15), 3.25 (s, 3H, OCH3). 13C NMR (100 MHz,
DMSO‐d6, δ, ppm): 141.7 (imidazol), 139.3 (Ph), 132.9
(Ph), 128.3 (Ph), 125.1 (Ph), 123.7 (imidazol), 123.1
(imidazol), 69.1 ((CH2CH2O)15), 68.5 (NCH2CH2O), 59.3
(OCH3), 49.1 (NCH2CH2O), 36.7 (NCH3). 31P NMR
(DMSO‐d6, δ, ppm): −34.7.
6a Yield: 83.1%. 1H NMR (400 MHz, DMSO‐d6, δ,
ppm): 7.91 (s, 1H, imidazol), 7.61 (s, 1H, imidazol),